RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

raloxifene hydrochloride, Quantity: 60 mg

Mevcut itibaren:

MedTAS Pty Ltd

INN (International Adı):

Raloxifene hydrochloride

Farmasötik formu:

Tablet, film coated

Kompozisyon:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

Uygulama yolu:

Oral

Paketteki üniteler:

28 tablets

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

Ürün özeti:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2014-01-14